You will lead the commercial strategy for a pioneering company focused on rare tumors, working on meaningful therapies that address unmet patient needs. The role offers high-level P&L responsibility, strategic impact, and the opportunity to build and lead a team from the ground up. Being part of Merck KGaA provides the stability and resources of a global science and technology leader.
The role carries full P&L responsibility, meaning significant pressure to meet financial and commercial targets in a competitive and regulated market. Working in the rare disease space involves navigating complex market access hurdles with payers and healthcare systems. Leading a cross-functional team in a new or growing market requires strong change management and alignment skills.
This position is ideal for an experienced pharmaceutical executive with a strong commercial track record, a passion for rare diseases, and the ambition to lead and grow a country's business operations from a strategic and operational standpoint.
缺点 / 挑战
暂无明显挑战项
角色解读
This role is a senior leadership position (Country Lead) with significant autonomy and responsibility. Successful performance can lead to broader regional leadership roles (e.g., Regional Lead for Europe) or global functional leadership positions within Merck's Healthcare division. The experience in launching and commercializing drugs for rare diseases is a highly specialized and valuable career asset in the biopharma industry.
You will be the top leader for SpringWorks' operations in Belgium, responsible for setting the country's commercial strategy and ensuring its execution. Your core duties include managing the full Profit & Loss statement, leading a cross-functional team of professionals, and driving market access for rare oncology drugs. You will also represent the company to key external stakeholders like healthcare authorities and payer organizations.
You need extensive (10+ years) managerial experience in the pharmaceutical industry with a proven track record of delivering financial results at a country level. Strong leadership, strategic planning, and P&L management skills are essential. Experience in rare diseases, particularly oncology, is highly valued. Excellent communication and stakeholder engagement skills across diverse groups are crucial.
申请策略
Research SpringWorks Therapeutics' approved products (nirogacestat for desmoid tumors, mirdametinib for NF1-PN) and pipeline thoroughly. Understand Merck KGaA's broader Healthcare strategy and how SpringWorks fits within it. In your application and interviews, align your experience with the company's patient-centric mission and values of curiosity and urgency.
Quantify your achievements in previous country-level roles, specifically highlighting revenue growth, profit delivery, and successful drug launches. Detail your experience in full P&L management, strategic planning, and budget oversight. Emphasize any direct experience in rare diseases, oncology, or market access. Showcase your leadership experience in building, developing, and leading cross-functional teams.
If lacking, deepen your knowledge of the specific rare oncology landscape (desmoid tumors, NF1-PN) and the Belgian/European healthcare and reimbursement system. Brush up on the latest digital engagement and patient identification strategies relevant to rare diseases. Prepare to discuss concrete examples of your strategic thinking and problem-solving in complex environments.
面试指南
Use the STAR method (Situation, Task, Action, Result) to structure your answers, focusing on quantifiable results. For strategic questions, demonstrate a structured thought process: analyze the market/landscape, define clear objectives, outline a multi-pronged strategy, and explain how you would measure success. Always link your answers back to the core responsibilities of the Country Lead role and the company's mission.
"Walk us through your experience launching a pharmaceutical product in a new market. What were the key challenges and how did you overcome them?"
"Describe a time you had full P&L responsibility. How did you develop the strategic plan and what specific actions did you take to optimize costs and drive revenue?"
"How would you approach building a market access strategy for a rare disease drug in Belgium?"
"Tell us about your experience leading a cross-functional team. How do you foster collaboration and manage conflicting priorities?"
"Why are you interested in SpringWorks and the rare disease space specifically?"
Prepare 3-4 detailed case studies from your career that cover: a major commercial success (launch, turnaround, growth), a complex strategic challenge you solved, and an example of effective team leadership. Research the Belgian pharmaceutical market, key opinion leaders in oncology, and the regulatory/payer environment. Be ready to discuss your 90-day plan for entering the role.